Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa

被引:131
|
作者
Denny, Lynette [1 ]
Adewole, Isaac [2 ]
Anorlu, Rose [3 ]
Dreyer, Greta [4 ]
Moodley, Manivasan [5 ]
Smith, Trudy [6 ]
Snyman, Leon [4 ]
Wiredu, Edwin [7 ]
Molijn, Anco [8 ]
Quint, Wim [8 ]
Ramakrishnan, Gunasekaran [9 ]
Schmidt, Johannes [10 ]
机构
[1] Univ Cape Town, Groote Schuur Hosp, Dept Obstet & Gynecol, ZA-7925 Cape Town, South Africa
[2] Univ Ibadan, Coll Med, Ibadan, Nigeria
[3] Univ Lagos, Coll Med, Teaching Hosp, Dept Obstet & Gynecol, Lagos, Nigeria
[4] Univ Pretoria, Dept Obstet & Gynecol, ZA-0002 Pretoria, South Africa
[5] Inkosi Albert Luthuni Cent Hosp, Dept Obstet & Gynecol, Durban, South Africa
[6] Univ Witwatersrand, Charlotte Maxeke Johannesburg Acad Hosp, Dept Obstet & Gynecol, Johannesburg, South Africa
[7] Univ Ghana, Sch Allied Hlth Sci, Dept Pathol, Accra, Ghana
[8] DDL Diagnost Lab, Rijswijk, Netherlands
[9] GlaxoSmithKline Pharmaceut Ltd, Bangalore, Karnataka, India
[10] GlaxoSmithKline Vaccines, Wavre, Belgium
关键词
human papillomavirus; invasive cervical cancer; sub-Saharan Africa; HPV-16/18 AS04-ADJUVANTED VACCINE; OF-STUDY ANALYSIS; PARTICLE VACCINE; HPV TYPES; SUSTAINED EFFICACY; HIV-INFECTION; FOLLOW-UP; WOMEN; IMMUNOGENICITY; GENOTYPES;
D O I
10.1002/ijc.28425
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In sub-Saharan Africa, invasive cervical cancer (ICC) incidence and mortality are among the highest in the world. This cross-sectional epidemiological study assessed human papillomavirus (HPV) prevalence and type distribution in women with ICC in Ghana, Nigeria, and South Africa. Cervical biopsy specimens were obtained from women aged 21 years with lesions clinically suggestive of ICC. Histopathological diagnosis of ICC was determined by light microscopy examination of hematoxylin and eosin stained sections of paraffin-embedded cervical specimens; samples with a confirmed histopathological diagnosis underwent HPV DNA testing by polymerase chain reaction. HPV-positive specimens were typed by reverse hybridization line probe assay. Between October 2007 and March 2010, cervical specimens from 659 women were collected (167 in Ghana, 192 in Nigeria and 300 in South Africa); 570 cases were histologically confirmed as ICC. The tumor type was identified in 551/570 women with ICC; squamous cell carcinoma was observed in 476/570 (83.5%) cases. The HPV-positivity rate in ICC cases was 90.4% (515/570). In ICC cases with single HPV infection (447/515 [86.8%]), the most commonly detected HPV types were HPV16 (51.2%), HPV18 (17.2%), HPV35 (8.7%), HPV45 (7.4%), HPV33 (4.0%) and HPV52 (2.2%). The prevalence of single and multiple HPV infections seemed higher among HIV-positive women and HPV type distribution appeared to differ according to tumor type and HIV status. In conclusion, HPV16, 18, 45 and 35 were the most common HPV types in sub-Saharan African women with ICC and HPV infections were more common in HIV-positive women. What's new? This was the first study conducted in sub-Saharan Africa using standardized and validated methods for human papillomavirus (HPV) detection and typing, and centralized pathology review for confirmation of the histological diagnosis. In women with invasive cervical cancer from Ghana, Nigeria, and South Africa, the HPV-positivity rate was 90.4%, HPV16, 18, 45, and 35 were the most common types, and the prevalence of single and multiple HPV infections seemed higher among HIV-positive than among HIV-negative women.
引用
收藏
页码:1389 / 1398
页数:10
相关论文
共 50 条
  • [1] Human papillomavirus distribution in invasive cervical carcinoma in sub-Saharan Africa: could HIV explain the differences?
    Ndiaye, Cathy
    Alemany, Laia
    Ndiaye, Nafissatou
    Kamate, Bakarou
    Diop, Yankhoba
    Odida, Michael
    Banjo, Kunbi
    Tous, Sara
    Ellen Klaustermeier, Jo
    Clavero, Omar
    Castellsague, Xavier
    Xavier Bosch, F.
    Trottier, Helen
    de Sanjose, Silvia
    [J]. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2012, 17 (12) : 1432 - 1440
  • [2] Trials and Projects on Cervical Cancer and Human Papillomavirus Prevention in Sub-Saharan Africa
    Adefuye, Peter O.
    Broutet, Nathalie J.
    de Sanjose, Silvia
    Denny, Lynette A.
    [J]. VACCINE, 2013, 31 : F53 - F59
  • [3] Infrastructure Requirements for Human Papillomavirus Vaccination and Cervical Cancer Screening in Sub-Saharan Africa
    Sankaranarayanan, Rengaswamy
    Anorlu, Rose
    Sangwa-Lugoma, Ghislain
    Denny, Lynette A.
    [J]. VACCINE, 2013, 31 : F47 - F52
  • [4] Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review
    Louie, Karly S.
    de Sanjose, Silvia
    Mayaud, Philippe
    [J]. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2009, 14 (10) : 1287 - 1302
  • [5] Trends in cervical cancer incidence in sub-Saharan Africa
    Elima Jedy-Agba
    Walburga Yvonne Joko
    Biying Liu
    Nathan Gyabi Buziba
    Margaret Borok
    Anne Korir
    Leo Masamba
    Shyam Shunker Manraj
    Anne Finesse
    Henry Wabinga
    Nontuthuzelo Somdyala
    Donald Maxwell Parkin
    [J]. British Journal of Cancer, 2020, 123 : 148 - 154
  • [6] Trends in cervical cancer incidence in sub-Saharan Africa
    Jedy-Agba, Elima
    Joko, Walburga Yvonne
    Liu, Biying
    Buziba, Nathan Gyabi
    Borok, Margaret
    Korir, Anne
    Masamba, Leo
    Manraj, Shyam Shunker
    Finesse, Anne
    Wabinga, Henry
    Somdyala, Nontuthuzelo
    Parkin, Donald Maxwell
    [J]. BRITISH JOURNAL OF CANCER, 2020, 123 (01) : 148 - 154
  • [7] Recommendations for Cervical Cancer Prevention in Sub-Saharan Africa
    Denny, Lynette A.
    Sankaranarayanan, Rengaswamy
    De Vuyst, Hugo
    Kim, Jane J.
    Adefuye, Peter O.
    Alemany, Laia
    Adewole, Isaac F.
    Awolude, Olutosin A.
    Parham, Groesbeck
    de Sanjose, Silvia
    Bosch, F. Xavier
    [J]. VACCINE, 2013, 31 : F73 - F74
  • [8] Human Papillomavirus type distribution in invasive cervical cancer in Uganda
    Odida M.
    de Sanjosé S.
    Quint W.
    Bosch X.F.
    Klaustermeier J.
    Weiderpass E.
    [J]. BMC Infectious Diseases, 8 (1)
  • [9] Cancer in sub-Saharan Africa
    Rebbeck, Timothy R.
    [J]. SCIENCE, 2020, 367 (6473) : 27 - 28
  • [10] Cervical Cancer Prevention in sub-Saharan Africa: A Policy Analysis
    Akanda, Rifa
    Moucheraud, Corrina
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2021, 30 (07)